The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
NKTR-102 in patients with platinum-resistant ovarian cancer (PROC): Modeling CA125 response and its correlation with tumor response.
Yen Lin Chia
Employment or Leadership Position - Nektar
Stock Ownership - Nektar
Ute Hoch
Employment or Leadership Position - Nektar
Stock Ownership - Nektar
Abraham C. F. Leung
Employment or Leadership Position - Nektar (I)
Michael A. Eldon
Employment or Leadership Position - Nektar
Stock Ownership - Nektar